Metformin for PCOS: What It Does, Who Needs It, and How Long to Take It

Metformin is one of the most frequently prescribed medications in PCOS management in India — and one of the most frequently misunderstood. Some women have been taking it for years without a clear explanation of what it is doing. Others have been told they do not need it when the evidence suggests they might benefit. This article explains exactly what metformin does in PCOS, who is likely to benefit, what the side effects involve, and how long treatment is appropriate.

What Is Metformin and How Does It Work?

Metformin (biguanide class) was originally developed as a diabetes medication. Its primary mechanism of action is reducing hepatic (liver) glucose production — the liver's tendency to release excess glucose into the bloodstream, particularly overnight and in the fasting state. It also improves insulin sensitivity in peripheral tissues (muscle and fat cells), making them more responsive to insulin's signal to absorb glucose.

In PCOS, the benefit flows from this improved insulin sensitivity:

• Reduced circulating insulin reduces the stimulus for ovarian androgen production — lowering testosterone and its derivatives.
• Lower androgens allow more normal follicle development and increase the frequency of ovulation in anovulatory women.
• Reduced SHBG suppression (because insulin is lower) means more testosterone is bound and inactivated — less free testosterone to drive acne, hirsutism, and hair loss.
• Improved metabolic environment reduces long-term risk of progression to type 2 diabetes — metformin reduces this risk by approximately 31% in high-risk individuals over 3 years.

Who Benefits Most from Metformin in PCOS?

Metformin is not universally beneficial in every PCOS phenotype. The strongest evidence is for:

• Overweight women with PCOS and documented insulin resistance (elevated HOMA-IR, impaired fasting glucose, or impaired glucose tolerance on OGTT)
• Women with PCOS trying to conceive, particularly as an adjunct to letrozole-based ovulation induction — metformin combined with letrozole may improve ovulation rates compared to letrozole alone in insulin-resistant patients
• Women with PCOS periconceptionally — some evidence suggests metformin continued into the first trimester of pregnancy reduces early pregnancy loss rates and gestational diabetes risk
• PCOS patients preparing for IVF — pretreatment with metformin may reduce OHSS risk in high-responders
• Women with PCOS at high risk of progression to type 2 diabetes (family history, impaired glucose tolerance, BMI above 25 with central adiposity)

For lean women with PCOS without documented insulin resistance, the evidence for metformin benefit is weaker. Inositols (myo-inositol and D-chiro-inositol) are often preferred in this group, with a comparable insulin-sensitising effect and better tolerability in lean patients.

Metformin for PCOS Fertility: What the Evidence Shows

Multiple randomised trials have investigated metformin as a fertility treatment in PCOS. Key findings:

• Metformin alone is inferior to letrozole alone for ovulation induction in PCOS — it should not be used as the primary ovulation induction agent.
• Metformin combined with letrozole may improve ovulation and pregnancy rates in insulin-resistant women compared to letrozole alone — particularly in those who respond poorly to letrozole monotherapy.
• Metformin does not improve live birth rates in IVF for the general PCOS population when compared with no pretreatment — but may reduce OHSS risk.
• Preconceptional metformin in PCOS reduces early pregnancy loss risk in some studies — though evidence is not uniformly consistent.

The clinical implication: metformin is a useful adjunct to fertility treatment in PCOS, particularly in insulin-resistant patients, but it is not a standalone fertility treatment.

Dosage and Starting Metformin

Standard metformin dosing in PCOS:

• Starting dose: 500 mg once daily with the evening meal for 1 to 2 weeks
• Gradual increase: to 500 mg twice daily, then 500 mg three times daily (or 850 mg twice daily), over 4 to 6 weeks
• Target dose: 1500 to 2000 mg daily in divided doses — the dose where the majority of metabolic benefit is achieved

Gradual dose escalation is essential — it significantly reduces the gastrointestinal side effects (nausea, diarrhoea) that cause many women to stop metformin prematurely. Taking metformin with food also minimises GI discomfort.

Side Effects and Tolerability

The main side effects of metformin are gastrointestinal — nausea, loose stools, abdominal cramping, and diarrhoea. These are dose-dependent and most prominent in the first 2 to 4 weeks of treatment. They reduce significantly with gradual dose escalation and consistent intake with food.

A small proportion of women do not tolerate standard metformin. Extended-release (ER) or modified-release formulations of metformin produce lower GI side effects for most patients and are an alternative for those who experience significant GI intolerance on immediate-release formulations.

Rare but important: Metformin can cause vitamin B12 deficiency with long-term use (typically after 3 to 5 years). B12 levels should be checked annually in women on long-term metformin, with supplementation if levels are low.

How Long Should Metformin Be Taken?

There is no universal answer — it depends on the indication:

• For fertility treatment: Typically taken periconceptionally — before and through the first trimester. Some doctors continue through pregnancy; discuss with your specialist.
• For cycle regulation and symptom management (not trying to conceive): Metformin is often used alongside OCP. It addresses the metabolic driver while OCP manages symptoms. Duration is individualised based on metabolic response.
• For long-term diabetes prevention: There is a strong case for long-term (years) metformin use in PCOS women with documented insulin resistance or impaired glucose tolerance — with annual B12 monitoring.
• When to consider stopping: When BMI and insulin sensitivity have normalised through lifestyle changes, or when a woman is pregnant and the obstetrician advises otherwise.

Frequently Asked Questions

Q1. Will I gain weight on metformin?

No — metformin is weight-neutral or mildly weight-reducing in most patients. It does not cause weight gain. In some overweight women with PCOS, metformin supports modest weight loss by improving insulin sensitivity and reducing appetite modestly. It is not, however, a primary weight loss medication.

Q2. Can I take metformin with inositols?

Yes — metformin and inositols can be used together. They work through different mechanisms and the combination may offer additive benefit. Some PCOS specialists use low-dose metformin (500 to 1000 mg/day) alongside myo-inositol (2 to 4g/day) in patients who experience significant side effects at full metformin doses. Discuss the combination with your doctor.

Q3. My doctor prescribed metformin but did not test for insulin resistance. Should I still take it?

Testing for insulin resistance (HOMA-IR, fasting glucose and insulin, or OGTT) before prescribing metformin is best practice — it clarifies whether insulin resistance is actually present and documents baseline metabolic status. If testing was not done, it is reasonable to ask for it before starting, or to ask your doctor to explain the clinical rationale for the prescription.